38 related articles for article (PubMed ID: 11018791)
1. Facilitation of sexual behavior and enhanced dopamine efflux in the nucleus accumbens of male rats after D-amphetamine-induced behavioral sensitization.
Fiorino DF; Phillips AG
J Neurosci; 1999 Jan; 19(1):456-63. PubMed ID: 9870973
[TBL] [Abstract][Full Text] [Related]
2. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats.
Grignaschi G; Fanelli E; Scagnol I; Samanin R
Br J Pharmacol; 1999 Jul; 127(5):1190-4. PubMed ID: 10455265
[TBL] [Abstract][Full Text] [Related]
3. Effects of the MEK inhibitor, SL-327, on rewarding, motor- and cellular-activating effects of D-amphetamine and SKF-82958, and their augmentation by food restriction in rat.
Carr KD; de Vaca SC; Sun Y; Chau LS; Pan Y; Dela Cruz J
Psychopharmacology (Berl); 2009 Jan; 201(4):495-506. PubMed ID: 18766328
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Phentermine and its Derivatives.
Upadhyaya K; Shukla S; Meena BP; Dwivedi J
Curr Org Synth; 2024; 21(5):583-594. PubMed ID: 37259208
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the serotonin saga: from discovery to weight regulation and beyond - a comprehensive scientific review.
Conde K; Fang S; Xu Y
Cell Biosci; 2023 Aug; 13(1):143. PubMed ID: 37550777
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Dimitri P
Front Endocrinol (Lausanne); 2022; 13():846880. PubMed ID: 35464063
[TBL] [Abstract][Full Text] [Related]
7. What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.
Heal DJ; Gosden J
Int J Obes (Lond); 2022 Apr; 46(4):677-695. PubMed ID: 34992243
[TBL] [Abstract][Full Text] [Related]
8. Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
Heal DJ; Smith SL
J Psychopharmacol; 2022 Jun; 36(6):680-703. PubMed ID: 34318734
[TBL] [Abstract][Full Text] [Related]
9. 5-alpha-dihydrotestosterone elevations associated with phentermine use.
Pearson SM; Trujillo JM; McDermott MT
Ther Adv Endocrinol Metab; 2018; 9(8):255-258. PubMed ID: 30181851
[TBL] [Abstract][Full Text] [Related]
10. Stimulants for the Control of Hedonic Appetite.
Poulton AS; Hibbert EJ; Champion BL; Nanan RK
Front Pharmacol; 2016; 7():105. PubMed ID: 27199749
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine, past and present--a pharmacological and clinical perspective.
Heal DJ; Smith SL; Gosden J; Nutt DJ
J Psychopharmacol; 2013 Jun; 27(6):479-96. PubMed ID: 23539642
[TBL] [Abstract][Full Text] [Related]
12. The use of serotonergic drugs to treat obesity--is there any hope?
Bello NT; Liang NC
Drug Des Devel Ther; 2011 Feb; 5():95-109. PubMed ID: 21448447
[TBL] [Abstract][Full Text] [Related]
13. MSI-1436 reduces acute food intake without affecting dopamine transporter activity.
Roitman MF; Wescott S; Cone JJ; McLane MP; Wolfe HR
Pharmacol Biochem Behav; 2010 Nov; 97(1):138-43. PubMed ID: 20478327
[TBL] [Abstract][Full Text] [Related]
14. The anorexic agents, sibutramine and fenfluramine, depress GABA(B)-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells.
Ledonne A; Sebastianelli L; Federici M; Bernardi G; Mercuri NB
Br J Pharmacol; 2009 Mar; 156(6):962-9. PubMed ID: 19298257
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system biogenic amine targets for control of appetite and energy expenditure.
Nelson DL; Gehlert DR
Endocrine; 2006 Feb; 29(1):49-60. PubMed ID: 16622292
[TBL] [Abstract][Full Text] [Related]
16. Antiobesity drugs: current and future issues.
Hatahet MA; Dhurandhar NV
Curr Diab Rep; 2002 Oct; 2(5):409-15. PubMed ID: 12643166
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of systemic and central sibutramine administration on the intake of a palatable diet in the rat.
Pratt WE; Connolly ME
Neurosci Lett; 2010 Oct; 484(1):30-4. PubMed ID: 20705119
[TBL] [Abstract][Full Text] [Related]
19. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
